Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach.

This is a source-metadata record last found in a complete check on Sep 25, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.

Source status: This saved record has not yet had a scheduled exact-ID status check. Check its original source links.

Study metadata

Study type: Original study
Study category (metadata hint): Other or unclear
Published: 2021-05-18
Authors: Fourman LT, Stanley TL, Billingsley JM, Sui SJH, Feldpausch MN, Boutin A, Zheng I, McClure CM
Journal or registry: Not reported
Registry study design: Not reported
Registry enrollment: Not reported
Funding agencies: National Institutes of Health; NIAID NIH HHS; NICHD NIH HHS; NIH HHS; Massachusetts General Hospital; National Cancer Institute; NIDDK NIH HHS
Identifiers: DOI: 10.1038/s41598-021-89966-y · PMID: 34006921 · PMCID: PMC8131688
First found: Sep 25, 2026
Last found: Sep 25, 2026

Original sources

View at Europe PMC ↗